Aclaris Therapeutics Inc (ACRS)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Aclaris Therapeutics: Charting a Path to Financial Reinvention and Leadership Reinforcement
JAK Inhibitor ATI-1777: A Promising New Development in Atopic Dermatitis Treatment.
2. Aclaris Therapeutics Inc: Paving the Way for Innovative Healthcare Solutions
Aclaris Therapeutics Inc Reports Larger Loss in Q3 2023, Exceeding Previous Year*s Figures
Very strong information, by the company over the financial span closing Sep 30 2022